BRIEF-ContraVir Pharmaceuticals announces issuance of new U.S. patent for expansion of cyclophilin inhibitor program

* ContraVir Pharmaceuticals announces issuance of new US patent for expansion of cyclophilin inhibitor program
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.